Skip to main content

Table 4 Outcomes

From: Management and endovascular therapy of ureteroarterial fistulas: experience from a single center and review of the literature

Case

Patient

Technical success

Early clinical success

Periprocedural complication

Stent thrombosis (days)

Recurrent bleeding (days)

Follow-up data

1

1

yes

yes

–

no

no

uneventful at 4 days

2

2

yes

yes

–

no

no

uneventful at 1 days

3

3

yes

yes

Not fully unfolded stent

yes (2)

yes (229)

death at 229 days due to recurrent hemorrhage

4

4

yes

yes

–

no

no

uneventful at 3 days

5

5

yes

yes

–

no

no

uneventful at 69 days

6

6

yes

yes

–

no

no

uneventful at 186 days

7

7

yes

no

–

no

yes (8)

alive at 11 days

8

8

yes

yes

–

no

no

uneventful at 1390 days

9

9

yes

yes

–

no

no

uneventful at 846 days

10

10

yes

yes

–

no

no

uneventful at 1237 days

11

11

yes

no

–

no

yes (13)

alive at 763 days

12

12

yes

yes

Closure device failure

yes (1)

no

alive at 220 days

13

13

yes

yes

–

no

no

uneventful at 1984 days

14

14

yes

yes

–

yes (58)

no

alive at 3269 days

15

15

yes

yes

–

no

no

alive at 187 days

16

16

yes

no

–

no

yes (8)

death at 576 days due to underlying disease

17

15

yes

yes

–

no

no

alive at 147 days

Total (%)

 

17 (100%)

14 (82.4%)

2 (11.8%)

3 (17.7%)

4 (23.5%)

Mean follow-up 654 (Range: 1–1984) days